Tafamidis

Tafamidis is a medicine used to treat transthyretin amyloid cardiomyopathy (ATTR-CM) in adults. ATTR-CM is a rare, inherited disease that affects the heart, causing it to become enlarged and unable to pump blood effectively. Tafamidis works by stabilizing and preventing the buildup of proteins in the heart, which can help reduce symptoms and improve quality of life. It is taken as a once-daily capsule. Common side effects may include headache, diarrhea, and dizziness.

Tafamidis is a medication used to treat transthyretin amyloidosis (ATTR amyloidosis), a condition in which a protein called transthyretin misfolds and deposits in the body, damaging tissues including nerves and the heart. It is sold under the brand names Vyndaqel and Vyndamax .

Tafamidis works by stabilizing the transthyretin protein, preventing it from misfolding and clumping together. This can help to slow the progression of ATTR amyloidosis and improve symptoms.

Tafamidis is available as a capsule that is taken by mouth once daily. It is important to take tafamidis exactly as prescribed by your doctor.

Tafamidis can cause some side effects, including diarrhea, nausea, and headache. These side effects are usually mild and go away on their own. However, it is important to tell your doctor if you experience any side effects that bother you.

Tafamidis is a relatively new medication, and it is not yet known what the long-term effects of taking it are. It is important to talk to your doctor about the risks and benefits of taking tafamidis before you start treatment.

Here are some additional things to keep in mind about tafamidis:

• Tafamidis is not a cure for ATTR amyloidosis, but it can help to slow the progression of the disease.
• Tafamidis is only available by prescription.
• Tafamidis can interact with other medications, so it is important to tell your doctor about all of the medications you are taking before you start taking tafamidis.
• If you are pregnant or breastfeeding, you should not take tafamidis.